Coeptis Therapeutics Holdings, Inc. financial data

Symbol
COEP, COEPW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
105 Bradford Road, Suite 420, Wexford, Pennsylvania
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Bull Horn Holdings Corp. (to 10/28/2022)
Latest financial report
Q1 2024 - May 10, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 160 % +86.1%
Debt-to-equity 112 % -8.8%
Return On Assets -205 % -56.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 36.1M shares +76.6%
Common Stock, Shares, Outstanding 36.4M shares +74%
Entity Public Float 28.8M USD -42.4%
Common Stock, Value, Issued 3.64K USD +74%
Weighted Average Number of Shares Outstanding, Basic 35.5M shares +77%
Weighted Average Number of Shares Outstanding, Diluted 35.5M shares +77%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD
Cost of Revenue 0 USD
Research and Development Expense 7.33M USD +5281%
Selling and Marketing Expense 12.7K USD +52.6%
General and Administrative Expense 3.88M USD -20.2%
Operating Income (Loss) -17.9M USD +28.6%
Nonoperating Income (Expense) 1.56M USD +94.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -16.3M USD +38.1%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -16.3M USD +38.1%
Earnings Per Share, Basic -0.51 USD/shares +66.2%
Earnings Per Share, Diluted -0.51 USD/shares +66.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 13.8K USD -97.6%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Assets, Current 6.88M USD +202%
Property, Plant and Equipment, Net 11.1K USD -9.3%
Operating Lease, Right-of-Use Asset 88.4K USD +80.3%
Assets 9.39M USD +58.1%
Accounts Payable, Current 1.37M USD +463%
Accrued Liabilities, Current 719K USD +144%
Liabilities, Current 4.3M USD +77.8%
Operating Lease, Liability, Noncurrent 61.2K USD +316%
Liabilities 5.03M USD -1.2%
Retained Earnings (Accumulated Deficit) -90.4M USD -22%
Stockholders' Equity Attributable to Parent 4.36M USD +415%
Liabilities and Equity 9.39M USD +58.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.9M USD -12.9%
Net Cash Provided by (Used in) Financing Activities 1.56M USD
Net Cash Provided by (Used in) Investing Activities -100K USD
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 36.4M shares +74%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.03M USD -51.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 23.1M USD +23.2%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.3 pure -3.25%
Deferred Tax Assets, Gross 23.1M USD +23.2%
Operating Lease, Liability 90.1K USD +94.8%
Payments to Acquire Property, Plant, and Equipment 0 USD
Lessee, Operating Lease, Liability, to be Paid 103K USD +96.8%
Property, Plant and Equipment, Gross 25.2K USD 0%
Operating Lease, Liability, Current 29K USD -8.24%
Lessee, Operating Lease, Liability, to be Paid, Year Two 46K USD +146%
Lessee, Operating Lease, Liability, to be Paid, Year One 34.1K USD +1.14%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 13.2K USD +112%
Lessee, Operating Lease, Liability, to be Paid, Year Three 23.2K USD
Deferred Tax Assets, Operating Loss Carryforwards 22.5M USD +21.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 94.7M USD +27.7%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 250K USD -0.04%
Interest Expense 277K USD +42.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%